Global Biochemistry Analyzers Market Attractiveness Analysis By Application, 2016-2024

The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. In addition to this, the accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe.

Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors. A recent report published by Persistence Market Research projects that by the end of 2024, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.

Key findings in the report cited that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins are gaining traction. The report currently values the global biochemistry analyzer market at a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.

Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/6451

The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024Key Research Insights from the Report include:

• Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patient’s metabolic functions

• Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America

• Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR

• Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers – a cost-effective upgrade to the existing product lines.

Request for Customization Here @ https://www.persistencemarketresearch.com/request-customization/6451

Company Profiles

• Roche Diagnostics GmbH

• Siemens AG

• Beckman Coulter Inc.

• Abbott Diagnostics Inc.

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Hologic, Inc.

• Randox Laboratories Ltd.

• Awareness Technology, Inc.

• Transasia Biomedicals Ltd

• Nova Biomedical Corp.

• Others

The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted for by sales of fully-automated biochemistry analyzers.

Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR. The report further identifies diagnostic centers as the largest end-users of biochemistry analyzers in the world.

On the other hand, a rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procuring over two-third of global biochemistry analyzers revenues through 2024.

For In-Depth Competitive Analysis, Buy now @ https://www.persistencemarketresearch.com/checkout/6451

The use of biochemistry analyzers in drug development applications is also expected to gain traction in the future. Based on modality, the report forecasts that in 2016, more than 70% of the market value was accounted for by bench-top biochemistry analyzers. However, towards the end of the forecast period, the demand for bench-top modality will incur a marginal decline, while floor standing biochemistry analyzers will bring in over US$ 1,200 Mn revenues.

More about the Life Sciences & Transformational Health –

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Get Similar Articles

Immunoassay Interference Blocker Market - Immunoassay Interference Blocker Market Segmented in Heterophilic Interference Blocker by Human Serum Derived Blockers, Animal Serum Derived Blockers, Human Immunoglobulin Blockers Applied in Sandwich Immunoassay, Antibody Capture Assays, Competitive ELISA. For More Infomation.

Circulating Tumor DNA Diagnostics Market - Some of the key players across the value chain of Circulating tumor DNA Diagnostics market are Grail, Inc., Guardant Health, Inc., Biodesix, Inc., Exosome Diagnostics, Freenome Inc., LungLife AI, Inc., Inivata Ltd., Personal Genome Diagnostics, Inc., CellMax Life, and others. For More Information.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us: